Goldman Sachs
CHE icon

Goldman Sachs’s Chemed CHE Stock Holding History

Goldman Sachs’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-16,200
Closed -$1.52M – 7123
2014
Q2 		$1.52M Buy
+16,200
New +$1.44M ﹤0.01% 4284

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Epoch Investment Partners
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Goldman Sachs's CHE Position: Q2 2026 in Review

Goldman Sachs increased its Chemed (CHE) stake by 33% in Q2 2026, buying an estimated $19.3M and bringing the position to 183,938 shares worth $85.7M. The position accounts for 0.01% of the portfolio, ranked #1348.

Goldman Sachs first reported a position in CHE in Q2 2013 and has held it in 53 quarters since. The position peaked at $86.7M in Q2 2018. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Goldman Sachs held 183,938 shares of Chemed worth $85.7M as of Q2 2026.
  • Goldman Sachs bought 45,939 Chemed shares in Q2 2026, an estimated $19.3M.
  • Chemed made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1348 holding.
  • Goldman Sachs first reported a position in Chemed in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's Chemed position peaked at $86.7M in Q2 2018.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.